Related Experiment Video
Updated: Jun 29, 2025

RNAscope for In situ Detection of Transcriptionally Active Human Papillomavirus in Head and Neck Squamous Cell Carcinoma
Published on: March 11, 2014
PIP4K2B Protein Regulation by NSD1 in HPV-Negative Head and Neck Squamous Cell Carcinoma
Iuliia Topchu1,2, Igor Bychkov1,3, Ekaterina Roshchina1
1Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Division of Hematology/Oncology, Northwestern University, Chicago, IL 60611, USA.
Abstract:
Head and neck squamous cell carcinoma (HNSCC) ranks among the most prevalent global cancers. Despite advancements in treatments, the five-year survival rate remains at approximately 66%. The histone methyltransferase NSD1, known for its role in catalyzing histone H3 lysine 36 di-methylation (H3K36me2), emerges as a potential oncogenic factor in HNSCC. Our study, employing Reverse Phase Protein Array (RPPA) analysis and subsequent validation, reveals that PIP4K2B is a key downstream target of NSD1. Notably, PIP4K2B depletion in HNSCC induces downregulation of the mTOR pathway, resulting in diminished cell growth in vitro. Our investigation highlights a direct, positive regulatory role of NSD1 on PIP4K2B gene transcription through an H3K36me2-dependent mechanism. Importantly, the impact of PIP4K2B appears to be context-dependent, with overexpression rescuing cell growth in laryngeal HNSCC cells but not in tongue/hypopharynx cells. In conclusion, our findings implicate PIP4K2B as a novel NSD1-dependent protein in HNSCC, suggesting its potential significance for laryngeal cancer cell survival. This insight contributes to our understanding of the molecular landscape in HNSCC and establishes PIP4KB as a promising target for drug development.
Insights
This study identifies PIP4K2B as a key downstream target of NSD1 in head and neck squamous cell carcinoma (HNSCC). NSD1 regulates PIP4K2B, impacting cancer cell growth, particularly in laryngeal HNSCC.
Area of Science:
- Oncology
- Molecular Biology
- Epigenetics
Background:
- Head and neck squamous cell carcinoma (HNSCC) has a persistent low survival rate.
- The histone methyltransferase NSD1 is implicated as a potential oncogenic factor in HNSCC.
Purpose of the Study:
- To investigate the role of NSD1 in HNSCC pathogenesis.
- To identify downstream targets of NSD1 and their impact on cancer cell growth.
Main Methods:
- Reverse Phase Protein Array (RPPA) analysis.
- Validation studies to confirm molecular interactions.
- In vitro cell growth assays.
Main Results:
- PIP4K2B identified as a key downstream target of NSD1 in HNSCC.
- NSD1 positively regulates PIP4K2B transcription via H3K36me2.
- PIP4K2B depletion downregulates the mTOR pathway, inhibiting cell growth.
- PIP4K2B overexpression rescues growth in laryngeal HNSCC cells.
Conclusions:
- PIP4K2B is a novel NSD1-dependent protein in HNSCC.
- PIP4K2B plays a context-dependent role in HNSCC cell survival.
- PIP4K2B is a potential therapeutic target for laryngeal cancer.
Related Concept Videos
Negative Regulator Molecules
Inhibition of Cdk Activity
Abnormal Proliferation
Covalently Linked Protein Regulators
These groups modify specific amino acids in a protein....
The JAK-STAT Signaling Pathway

